Extending value long after the clinical trial with real-world data
In our ongoing series, we have been discussing the value of real-world data (RWD) throughout the...
In our ongoing series, we have been discussing the value of real-world data (RWD) throughout the...
Two years ago, HealthVerity launched the Maternal Outcomes Masterset (MOM) to address the...
The COVID-19 pandemic illustrated how vital government communications can be for effective public...
Medicaid provides much-needed healthcare coverage to over 70 million people, almost half of whom...
While the CDC is considered the nation’s leading authority on infectious diseases, it is also...
Our series on how Privacy Preserving Record Linkage (PPRL) technology can help government agencies...
In our ongoing series on how Privacy-Preserving Record Linkage (PPRL) technology can help...
One in eight women in the U.S. will be diagnosed with breast cancer in their lifetime, that’s one...
In case you missed it, at the end of August, the FDA released new guidance on how to approach...
In our series on how Privacy-Preserving Record Linkage (PPRL) technology can help government...
Healthcare data now accounts for approximately 30% of global data volume and with this surge in data, life sciences organizations have access to more information than ever before. Some disruptions expand what you can do: new data owners entering the ...